David M Rogers is a notable inventor based in Ulverston, GB. He has made significant contributions to the field of antibiotic compounds, holding a total of three patents. His work focuses on the development of cephalosporins, which are crucial in the fight against bacterial infections.

Latest Patents

Among his latest patents, Rogers has developed cephalosporins featuring a carbamoylalkoxyiminoarylacetamido group. These antibiotic compounds are characterized by a general formula that includes various substituents, such as phenyl, thienyl, or furyl groups. Additionally, he has patented cephalosporin compounds that have an α-etherified structure at position-7, which also includes a range of substituents that enhance their efficacy and safety.

Career Highlights

Throughout his career, David M Rogers has worked with prominent companies in the pharmaceutical industry, including Glaxo Laboratories Limited and Glaxo Operations UK Limited. His experience in these organizations has allowed him to contribute to the advancement of antibiotic research and development.

Collaborations

Rogers has collaborated with notable colleagues, including Michael W Foxton and Gordon Ian Gregory. These partnerships have played a vital role in his innovative work and the successful development of his patented compounds.

Conclusion

David M Rogers is a distinguished inventor whose work in antibiotic compounds has made a significant impact in the medical field. His patents reflect his dedication to improving healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com